These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 20301140)
1. The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low-weight children: a novel procedure. Schneiderman J; Jacobsohn DA; Collins J; Thormann K; Kletzel M J Clin Apher; 2010; 25(2):63-9. PubMed ID: 20301140 [TBL] [Abstract][Full Text] [Related]
2. Photopheresis in pediatric patients with low-body weight using the UVAR XTS system. Hillen U; Meyer S; Schadendorf D; Kremens B J Dtsch Dermatol Ges; 2010 Jan; 8(1):32-7. PubMed ID: 19751224 [TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis in children with graft-versus-host disease. Chan KW J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229 [TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841 [TBL] [Abstract][Full Text] [Related]
5. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications. Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292 [TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease. Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179 [TBL] [Abstract][Full Text] [Related]
7. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature. Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513 [TBL] [Abstract][Full Text] [Related]
8. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease. Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621 [TBL] [Abstract][Full Text] [Related]
9. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance. Kusztal M; Kłak R; Krajewska M; Boratyńska M; Patrzałek D; Klinger M Transplant Proc; 2011 Oct; 43(8):2941-2. PubMed ID: 21996195 [TBL] [Abstract][Full Text] [Related]
10. The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients. Rangarajan HG; Punzalan RC; Camitta BM; Talano JA Br J Haematol; 2013 Nov; 163(3):357-64. PubMed ID: 23961954 [TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Kanold J; Paillard C; Halle P; D'Incan M; Bordigoni P; Deméocq F Transfus Apher Sci; 2003 Feb; 28(1):71-80. PubMed ID: 12620271 [TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840 [TBL] [Abstract][Full Text] [Related]
13. Safety and Outcomes of Extracorporeal Photopheresis With the Therakos Cellex System for Graft-Versus-Host Disease in Pediatric Patients. Uygun V; Daloglu H; Karasu G; Hazar V; Yeşilipek A J Pediatr Hematol Oncol; 2015 Apr; 37(3):209-14. PubMed ID: 25374287 [TBL] [Abstract][Full Text] [Related]
14. Successful extracorporeal photochemotherapy for chronic graft-versus-host disease in pediatric patients. Halle P; Paillard C; D'Incan M; Bordigoni P; Piguet C; De Lumley L; Stephan JL; Berger M; Rapatel C; Deméocq F; Kanold J J Hematother Stem Cell Res; 2002 Jun; 11(3):501-12. PubMed ID: 12183835 [TBL] [Abstract][Full Text] [Related]
15. Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD. González Vicent M; Ramirez M; Sevilla J; Abad L; Díaz MA J Pediatr Hematol Oncol; 2010 Nov; 32(8):589-93. PubMed ID: 20962677 [TBL] [Abstract][Full Text] [Related]
16. Update on the mechanism of action and on clinical efficacy of extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease in children. Goussetis E; Varela I; Tsirigotis P Transfus Apher Sci; 2012 Apr; 46(2):203-9. PubMed ID: 22079263 [TBL] [Abstract][Full Text] [Related]
17. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures. Perotti C; Torretta L; Viarengo G; Roveda L; Bernuzzi S; Carbone S; Del Fante C; La Torre R; Locatelli F; Bonetti F; Gabba P; Bellosta M; Salvaneschi L Haematologica; 1999 Mar; 84(3):237-41. PubMed ID: 10189389 [TBL] [Abstract][Full Text] [Related]